Results 41 to 50 of about 1,782,169 (280)

Epstein-Barr Virus LF2: an Antagonist to Type 1 Interferon [PDF]

open access: yes, 2009
Upon viral infection, the major defense mounted by the host immune system is activation of the interferon (IFN)-mediated antiviral pathway, which is mediated by IFN regulatory factors (IRFs).
Shin, Young Chul   +8 more
core   +1 more source

EBV infection assay.

open access: yes, 2023
A) Infection assays of BART(+/-)·S13+ EBV and Mt BART(+/-)·S13- EBV using HEK293 cells. EBV Infection was observed at different time-periods such as 0, 24, 48, and 96 h post-infection.
Sora Huh (14504838)   +11 more
core   +1 more source

Acute hepatitis: a rare complication of Epstein-Barr virus (EBV) infection [PDF]

open access: yes, 2010
Geyik, Mehmet Faruk/0000-0002-0906-0902WOS: 000208252700012PubMed: 21045362Infectious Mononucleosis (IM), a benign lymphoproliferative disease, is the best known clinical syndrome caused by Epstein-Barr Virus (EBV).
Uluğ, Mehmet   +9 more
core   +1 more source

Murine Model System for EBV-related Diseases [PDF]

open access: yes, 2007
Epstein-Barr Virus (EBV) is involved in several human malignancies via its latent gene products, which interact with cellular proteins and mimic discrete functions of cellular signalling pathways.
Zychlinska, Magdalena
core   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Innate immune modulation in EBV infection [PDF]

open access: yesHerpesviridae, 2011
Epstein-Barr Virus (EBV) belongs to the gammaherpesvirus family, members of which are oncogenic. Compared with other closely related herpesviruses, EBV has developed much more elaborate and sophisticated strategies for subverting host immune system, which may account for its high prevalence in immune competent hosts.
openaire   +2 more sources

Control of the EBV growth transformation programme: the importance of the Bamhi W repeats [PDF]

open access: yes, 2011
Epstein-Barr virus (EBV), a human gammaherpesvirus, possesses a unique set of latent genes whose constitutive expression in B cells leads to cell growth transformation.
Kao, Kuan-Yu
core   +6 more sources

The Negative Effect of Epstein-Barr Virus on the Response of Hepatitis C Virus Patients to Interferonribavirin Therapy

open access: yesJournal of Pure and Applied Microbiology, 2019
Of all viruses causing liver pathology, Epstein-Barr virus (EBV) has been one of the most ubiquitous. Presumably, a co-infection of both EBV and hepatitis C virus (HCV) negatively influences the prognosis of HCV-infected patients.
Abdel-Fattah Mohammed Attia   +4 more
doaj   +1 more source

Risk prediction for liver injury in Epstein-Barr virus infection in pediatric respiratory tract infections

open access: yesItalian Journal of Pediatrics, 2023
Background Epstein-Barr virus (EBV) infection is likely to co-occur in pediatric respiratory tract infections (RTIs). Liver injury is the common complication of EBV infection. The detailed risk factors for liver injury in EBV infection remain elusive. We
Song Mao, Liangxia Wu, Wenjing Shi
doaj   +1 more source

Epstein-Barr virus but not cytomegalovirus is associated with reduced vaccine antibody responses in Gambian infants. [PDF]

open access: yes, 2010
BACKGROUND: Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are persistent herpesviruses that have various immunomodulatory effects on their hosts. Both viruses are usually acquired in infancy in Sub-Saharan Africa, a region where childhood vaccines ...
Ebrima S Touray   +83 more
core   +1 more source

Home - About - Disclaimer - Privacy